Abstract
Abstract 5293
Cardiovascular Magnetic Resonance (CMR) has provided the opportunity to quantify right ventricular (RV) parameters with excellent reproducibility and accuracy. The role of the RV is gaining ground in thalassemia major (TM) patients and this population could experience different “normal” RV values due to chronic anemia and eventually pre-existing iron burdens. The aim of this study was to establish the ranges for normal RV volumes, mass and ejection fraction (EF) normalized to the influence of body surface area (BSA), age and sex from CMR in a large cohort of well-treated TM patients without myocardial iron overload.
Among the 923 TM patients enrolled in the Myocardial Iron Overload (MIOT) network who underwent CMR for the assessment of cardiac iron overload, function and fibrosis, we selected 142 patients with no known risk factors or history of cardiac disease, normal electrocardiogram, no myocardial iron overload (all the cardiac segments with a normal T2* value) and no myocardial fibrosis. All patients had been regularly transfused and chelated since early childhood. Moreover, we studied 71 healthy subjects matched for age and sex. RV function parameters were quantitatively evaluated in a standard way by SSFP cine images using MASS® software. RV end-diastolic volume (EDV), end-systolic volume (ESV) and stroke volume (SV) were normalized by body surface area (EDVI, ESVI, SVI).
The table shows the comparison of the CMR parameters with differentiation for sex and age in TM patients and healthy subjects and the cut-off of normality defined as mean – 2 standard deviation (SD). TM patients showed significantly lower BSA than the controls (P<0.0001). TM males (except age group 14–20 yrs) showed significantly higher RV EF compared to controls. In TM patients all LV volumes indexes were significantly larger in males than in females (P<0.0001 in all age groups). The EF was not different between the sexes. In males as well as in females the RV volumes were no significant different among the age groups, while in males the EF was significant different (P=0.004).
In a large cohort of well-treated TM patients males showed significantly higher RV EF compared to controls. Due to the influence of BSA, sex and age, appropriate “normal” reference ranges normalized to these variables should be used to avoid misdiagnosis of cardiomyopathy in the clinical arena in TM patients.
. | < 14 . | 14–20 . | 20–30 . | 30–40 . | >=40 . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | TM . | H . | P . | TM . | H . | P . | TM . | H . | P . | TM . | H . | P . | TM . | H . | P . |
Males | N=7 | N=7 | N=6 | N=6 | N=25 | N=15 | N=23 | N=11 | N=6 | N=5 | |||||
EDVI (ml/m2) | 88±16 (120) | 80±12 | 0.309 | 89±16 (121) | 89±17 | 0.946 | 96±21 (138) | 103±17 | 0.245 | 91±16 (123) | 82±13 | 0.139 | 90±13 (116) | 81±9 | 0.228 |
ESVI (ml/m2) | 26±3 (32) | 31±8 | 0.273 | 36±7 (50) | 35±9 | 0.931 | 34±8 (50) | 44±12 | 0.004 | 33±8 (49) | 33±8 | 0.952 | 28±6 (40) | 35±3 | 0.045 |
SVI (ml/m2) | 61±16 (93) | 49±6 | 0.108 | 53±11 (75) | 54±10 | 0.836 | 61±18 (97) | 60±9 | 0.882 | 58±11 (80) | 45±17 | 0.010 | 62±8 (78) | 46±8 | 0.007 |
EF (%) | 68±6 (56) | 62±5 | 0.048 | 59±5 (49) | 61±5 | 0.579 | 64±4 (56) | 58±6 | 0.001 | 64±5 (54) | 61±7 | 0.189 | 69±3 (63) | 57±5 | <0.0001 |
Females | N=2 | N=2 | N=8 | N=6 | N=24 | N=6 | N=33 | N=8 | N=8 | N=5 | |||||
EDVI (ml/m2) | 53±16 (85) | 61±1 | 0.587 | 77±8 (93) | 79±9 | 0.866 | 78±14 (106) | 78±12 | 0.990 | 73±13 (99) | 77±9 | 0.427 | 74±11 (96) | 70±16 | 0.648 |
ESVI (ml/m2) | 18±1 (20) | 20±4 | 0.656 | 29±5 (39) | 30±5 | 0.777 | 28±8 (44) | 31±9 | 0.378 | 24±7 (38) | 26±6 | 0.317 | 26±5 (36) | 25±12 | 0.922 |
SVI (ml/m2) | 35±5 (45) | 41±3 | 0.635 | 47±4 (55) | 49±7 | 0.673 | 51±9 (69) | 47±7 | 0.384 | 49±8 (65) | 51±10 | 0.738 | 47±6 (59) | 45±5 | 0.517 |
EF (%) | 64±9 (46) | 68±6 | 0.687 | 62±3 (56) | 62±6 | 0.997 | 65±6 (53) | 61±7 | 0.171 | 68±5 (58) | 66±8 | 0.329 | 67±6 (55) | 66±8 |
. | < 14 . | 14–20 . | 20–30 . | 30–40 . | >=40 . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | TM . | H . | P . | TM . | H . | P . | TM . | H . | P . | TM . | H . | P . | TM . | H . | P . |
Males | N=7 | N=7 | N=6 | N=6 | N=25 | N=15 | N=23 | N=11 | N=6 | N=5 | |||||
EDVI (ml/m2) | 88±16 (120) | 80±12 | 0.309 | 89±16 (121) | 89±17 | 0.946 | 96±21 (138) | 103±17 | 0.245 | 91±16 (123) | 82±13 | 0.139 | 90±13 (116) | 81±9 | 0.228 |
ESVI (ml/m2) | 26±3 (32) | 31±8 | 0.273 | 36±7 (50) | 35±9 | 0.931 | 34±8 (50) | 44±12 | 0.004 | 33±8 (49) | 33±8 | 0.952 | 28±6 (40) | 35±3 | 0.045 |
SVI (ml/m2) | 61±16 (93) | 49±6 | 0.108 | 53±11 (75) | 54±10 | 0.836 | 61±18 (97) | 60±9 | 0.882 | 58±11 (80) | 45±17 | 0.010 | 62±8 (78) | 46±8 | 0.007 |
EF (%) | 68±6 (56) | 62±5 | 0.048 | 59±5 (49) | 61±5 | 0.579 | 64±4 (56) | 58±6 | 0.001 | 64±5 (54) | 61±7 | 0.189 | 69±3 (63) | 57±5 | <0.0001 |
Females | N=2 | N=2 | N=8 | N=6 | N=24 | N=6 | N=33 | N=8 | N=8 | N=5 | |||||
EDVI (ml/m2) | 53±16 (85) | 61±1 | 0.587 | 77±8 (93) | 79±9 | 0.866 | 78±14 (106) | 78±12 | 0.990 | 73±13 (99) | 77±9 | 0.427 | 74±11 (96) | 70±16 | 0.648 |
ESVI (ml/m2) | 18±1 (20) | 20±4 | 0.656 | 29±5 (39) | 30±5 | 0.777 | 28±8 (44) | 31±9 | 0.378 | 24±7 (38) | 26±6 | 0.317 | 26±5 (36) | 25±12 | 0.922 |
SVI (ml/m2) | 35±5 (45) | 41±3 | 0.635 | 47±4 (55) | 49±7 | 0.673 | 51±9 (69) | 47±7 | 0.384 | 49±8 (65) | 51±10 | 0.738 | 47±6 (59) | 45±5 | 0.517 |
EF (%) | 64±9 (46) | 68±6 | 0.687 | 62±3 (56) | 62±6 | 0.997 | 65±6 (53) | 61±7 | 0.171 | 68±5 (58) | 66±8 | 0.329 | 67±6 (55) | 66±8 |
No relevant conflicts of interest to declare.
Author notes
Asterisk with author names denotes non-ASH members.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal